These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 15665705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 3. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA.
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [Abstract] [Full Text] [Related]

  • 4. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 5. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 6. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
    Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D, Microbiologists of Epibac, ORP Networks.
    Vaccine; 2015 Jan 03; 33(2):359-66. PubMed ID: 25448105
    [Abstract] [Full Text] [Related]

  • 7. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT.
    Clin Infect Dis; 2005 Jul 01; 41(1):21-9. PubMed ID: 15937758
    [Abstract] [Full Text] [Related]

  • 8. Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults.
    Shafinoori S, Ginocchio CC, Greenberg AJ, Yeoman E, Cheddie M, Rubin LG.
    Pediatr Infect Dis J; 2005 Jan 01; 24(1):10-6. PubMed ID: 15665704
    [Abstract] [Full Text] [Related]

  • 9. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I, Stevenson A, Hsu KK, Pelton SI.
    Pediatr Infect Dis J; 2012 Oct 01; 31(10):1016-21. PubMed ID: 22673142
    [Abstract] [Full Text] [Related]

  • 10. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
    Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W.
    JAMA; 2006 Apr 12; 295(14):1668-74. PubMed ID: 16609088
    [Abstract] [Full Text] [Related]

  • 11. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.
    Vaccine; 2012 Aug 31; 30(40):5880-5. PubMed ID: 22771186
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS.
    Pediatr Infect Dis J; 2008 Oct 31; 27(10):886-91. PubMed ID: 18776825
    [Abstract] [Full Text] [Related]

  • 14. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstein R, Hanage WP.
    Pediatr Infect Dis J; 2007 Jun 31; 26(6):468-72. PubMed ID: 17529860
    [Abstract] [Full Text] [Related]

  • 15. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 16. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
    Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG, Active Bacterial Core Surveillance Team.
    JAMA; 2005 Oct 26; 294(16):2043-51. PubMed ID: 16249418
    [Abstract] [Full Text] [Related]

  • 17. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.
    Clin Infect Dis; 2010 May 01; 50(9):1238-46. PubMed ID: 20367225
    [Abstract] [Full Text] [Related]

  • 18. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I, Shea KM, Little BA, Silverio AL, Pelton SI, Members of the Massachusetts Department of Public Health.
    Pediatrics; 2015 Mar 01; 135(3):495-503. PubMed ID: 25647674
    [Abstract] [Full Text] [Related]

  • 19. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R, D'Ambrosio F, Del Grosso M, Pimentel de Araujo F, Caporali MG, Del Manso M, Gherardi G, D'Ancona F, Pantosti A, Pneumococcal Surveillance Group.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [Abstract] [Full Text] [Related]

  • 20. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.